|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-4-8
|
|
pubmed:abstractText |
LyGDI is an inhibitor of Rho protein activation by blocking its transformation between guanosine 5'-diphosphate- and guanosine 5'-triphosphate-bound states. The aim of this study was to investigate the usefulness of LyGDI as a biomarker for the detection of ovarian cancer, and its specificity and sensitivity were compared with those of cancer antigen 125 (CA125).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
316-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20375790-Adenocarcinoma, Clear Cell,
pubmed-meshheading:20375790-Adenocarcinoma, Mucinous,
pubmed-meshheading:20375790-Adult,
pubmed-meshheading:20375790-Aged,
pubmed-meshheading:20375790-Aged, 80 and over,
pubmed-meshheading:20375790-CA-125 Antigen,
pubmed-meshheading:20375790-Case-Control Studies,
pubmed-meshheading:20375790-Cystadenocarcinoma, Serous,
pubmed-meshheading:20375790-Endometrial Neoplasms,
pubmed-meshheading:20375790-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20375790-Female,
pubmed-meshheading:20375790-Guanine Nucleotide Dissociation Inhibitors,
pubmed-meshheading:20375790-Humans,
pubmed-meshheading:20375790-Immunoenzyme Techniques,
pubmed-meshheading:20375790-Middle Aged,
pubmed-meshheading:20375790-Neoplasm Staging,
pubmed-meshheading:20375790-Ovarian Neoplasms,
pubmed-meshheading:20375790-Ovary,
pubmed-meshheading:20375790-Prognosis,
pubmed-meshheading:20375790-Sensitivity and Specificity,
pubmed-meshheading:20375790-Tumor Markers, Biological,
pubmed-meshheading:20375790-Tumor Suppressor Proteins
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
LyGDI is a promising biomarker for ovarian cancer.
|
|
pubmed:affiliation |
Department of Cell Biology, Peking University Health Science Center, Beijing, China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
